ARTICLE | Company News
Roche (SIX:ROG; OTCQX:RHHBY) launched its Ventana pan-TRK (EPR17341) assay to detect tropomyosin receptor kinase (Trk) proteins in cancer. Roche said the automated in vitro diagnostic (IVD) immunohistochemistry (IHC) assay enables identification of wild-type and Trk-fusion proteins through detection of the Trk C-terminal region...
BCIQ Company Profiles